24-11-2025 22:44 via medpagetoday.com

Cardiometabolic Gains Backslide After Halting Obesity Meds

(MedPage Today) -- Weight regain after the withdrawal of tirzepatide (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated.
Among 308 participants with obesity...
Read more »

Medical Industry news



FDA 'Priority Voucher' Program Comes Under Congressional Scrutiny
Highly Anticipated Alzheimer's Trials Yield Disappointing Results for GLP-1 Drug
Declassifying Nursing As 'Professional' Is a Grave Mistake
The MAHA Enterprise Explained
Abbott Reports 7 Deaths Linked to Glucose Sensor Problem
Social Media 'Detox' Linked to Better Mental Health for Young Adults
HPV Vaccination Tied to Huge Reduction in Cervical Cancer Risk
New Moms' GLP-1 Prescriptions Jumped After Wegovy Approval
Stopping GLP-1s for Pregnancy Linked to Weight Gain, Complications
Scandinavian Study Shreds COVID Vaccine-Myositis Link
I'm a Health Economist. Here's a Plan for Congress to Lower Healthcare Costs.
Zilucoplan for Myasthenia Gravis Improves Fatigue Beyond 2 Years in Trial
JFK's Granddaughter Reveals Terminal Cancer Diagnosis, Criticizes Cousin RFK Jr.
How to Make Treatment Decisions in Breast Cancer Without Genomic Assays
Desktop versie